Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1996-9-5
|
pubmed:abstractText |
The aim of the study was to use a virus-free system to transfer the Herpes Simplex Virus-thymidine kinase (HSV-TK) gene in mice bearing melanoma tumours. B16 F1 murine melanoma cells were injected subcutaneously. On days 11 and 14, an intratumoral injection of either naked plasmid containing the HSV-TK gene (pAG0) or pAG0-lipofectamine complexes was given. Ganciclovir (120 mg/kg/day) was given for 5 days starting on day 14. Tumour weight reduction (40-50%) was observed in treated animals versus different control groups. Moreover, histopathological analysis on tumours showed large areas of cavitary necrosis (85%) in treated groups compared to controls (10%). Using a simple and safe method, the results presented here demonstrated that virus-free mediated delivery of the HSV-TK gene is efficient in vivo in murine malignant melanoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0959-8049
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32A
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
691-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8695274-Animals,
pubmed-meshheading:8695274-Gene Transfer Techniques,
pubmed-meshheading:8695274-Genes, Viral,
pubmed-meshheading:8695274-Genetic Vectors,
pubmed-meshheading:8695274-Male,
pubmed-meshheading:8695274-Melanoma, Experimental,
pubmed-meshheading:8695274-Mice,
pubmed-meshheading:8695274-Mice, Inbred C57BL,
pubmed-meshheading:8695274-Simplexvirus,
pubmed-meshheading:8695274-Thymidine Kinase,
pubmed-meshheading:8695274-Viral Structural Proteins
|
pubmed:year |
1996
|
pubmed:articleTitle |
Direct gene transfer of a plasmid carrying the herpes simplex virus-thymidine kinase gene (HSV-TK) in transplanted murine melanoma: in vivo study.
|
pubmed:affiliation |
Medical Oncology Department, Salpetrière Hospital, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|